by Wyn Staheli, Director of Research
January 15th, 2021
On Friday, December 17, 2020, the AMA announced several changes in relation to the addition of new codes for the COVID-19 vaccine under development by AstraZeneca and University of Oxford. Codes 91302, 0021A, and 0022A were published on the AMA website and will be effective once they have received Emergency Use Authorization (EUA) from the FDA.
These additions necessitated some changes to other CPT guidelines. For more information, see the Resources below.